These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35696696)

  • 1. A Real-World Study of the Incidence and Outcomes of Early-Onset Well-differentiated Neuroendocrine Neoplasms.
    Abdel-Rahman O; Ghosh S
    Am J Clin Oncol; 2022 Aug; 45(8):338-343. PubMed ID: 35696696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary.
    Abdel-Rahman O
    Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Survival Outcomes of Patients With Neuroendocrine Neoplasms Over the Past 15 Years: A Real-World Study.
    Abdel-Rahman O; Pham TM; Pokhrel A; Ruether D; Sawyer MB
    Am J Clin Oncol; 2022 May; 45(5):208-214. PubMed ID: 35383575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
    Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
    Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
    Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
    Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
    JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
    Kuo EJ; Salem RR
    Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-based differences in the outcomes of patients with lung carcinoids.
    Abdel-Rahman O; Ghosh S; Fazio N
    J Comp Eff Res; 2022 May; 11(7):523-531. PubMed ID: 35388711
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
    Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
    Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cytoreductive surgery on outcomes of metastatic appendiceal carcinoma: a real-world, population-based study.
    Abdel-Rahman O
    J Comp Eff Res; 2020 Apr; 9(6):431-439. PubMed ID: 32253936
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
    Frizziero M; Wang X; Chakrabarty B; Childs A; Luong TV; Walter T; Khan MS; Morgan M; Christian A; Elshafie M; Shah T; Minicozzi A; Mansoor W; Meyer T; Lamarca A; Hubner RA; Valle JW; McNamara MG
    World J Gastroenterol; 2019 Oct; 25(39):5991-6005. PubMed ID: 31660035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
    Wu L; Fu J; Wan L; Pan J; Lai S; Zhong J; Chung DC; Wang L
    Oncotarget; 2017 Jan; 8(3):4935-4947. PubMed ID: 27903960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Nondigestive, Nonpulmonary Primary.
    Abdel-Rahman O; Ghosh S
    Pancreas; 2022 Aug; 51(7):769-773. PubMed ID: 36395402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors.
    Shi M; Zhou B
    Cancer Control; 2021; 28():1073274820986827. PubMed ID: 33491476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
    Schneiderman BA; Kliethermes SA; Nystrom LM
    Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Variation in Older Adults With Differentiated Thyroid Cancer.
    Sutton W; Canner JK; Segev DL; Zeiger MA; Mathur A
    J Surg Res; 2020 Oct; 254():154-164. PubMed ID: 32445931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study.
    Li YF; Zhang QQ; Wang WL
    Med Sci Monit; 2020 Jul; 26():e923375. PubMed ID: 32651994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database.
    Mirza FN; Tuggle CT; Zogg CK; Mirza HN; Narayan D
    J Am Acad Dermatol; 2018 Mar; 78(3):490-497.e1. PubMed ID: 28989104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.